BD Fiscal Q3 Revenues Jump 45 Percent on CareFusion Buy | GenomeWeb

NEW YORK (GenomeWeb) – Becton Dickinson said today that its fiscal third quarter revenues grew 45 percent year over year largely on its recent acquisition of medical technology firm CareFusion.

For the three months ended June 30, BD recorded revenues of $3.12 billion compared to $2.16 billion in fiscal Q3 2014, and just shy of the consensus analysts' estimate of $3.13 billion. On a comparable, currency-neutral basis, adjusted revenues grew just over 2 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.